MedTrace Logo

Chronic Kidney Disease (CKD) Guideline Adherence - A Quality Improvement Study

NCT00921687 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 781

Last updated 2013-05-27

Study results available
· View outcomes & findings →

Summary

Chronic kidney disease (CKD) is defined as kidney damage for greater than 3 months or a glomerular filtration rate less than 60 mL/min per 1.73m2 for greater than 3 months. Patients with CKD are at high risk for development of cardiovascular disease and metabolic complications. Guidelines for the care of patients with CKD have been developed by the National Kidney Foundation. Despite the wide availability of these guidelines, adherence is low. The goal of the current study is to evaluate whether a multifactorial intervention, including a CKD registry, will improve CKD guideline adherence. The hypothesis is that providers exposed to a multifactorial clinical intervention including education, academic detailing, and a CKD registry will be more likely to adhere to CKD guidelines than those only exposed to education.

Conditions

  • Chronic Renal Insufficiency

Interventions

BEHAVIORAL

Education only

The education will consist of a lecture and distribution of a CKD reference card.

BEHAVIORAL

Multifactorial intervention

Providers in the intervention group will receive a lecture on CKD, a CKD reference card, academic detailing (residents only), and access to the CKD registry.

Sponsors & Collaborators

  • Louis Stokes VA Medical Center

    lead FED

Principal Investigators

  • Paul E Drawz, MD, MHS, MS · Louis Stokes VA Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00921687 on ClinicalTrials.gov